Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Bergman

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
Lakartidningen|April 10, 1996
[Lists presented by eight drug committees compared. The number of preparations varies. Similar views on the most expensive drugs]U Bergman, M Myrhed
Lancet (London, England)|October 12, 1996
Risks with citalopram in perspectiveG Isacsson, U Bergman
NIDA Research Monograph|January 1, 1989
Current approaches to measurement of drug use and abuse in SwedenU Bergman, D Lee
Lakartidningen|July 27, 1994
[Uppsala at the bottom, Kopparberg at the top of the glaucoma list. Big differences in drug utilization]B Calissendorff, U Bergman
Lakartidningen|August 24, 1994
[Pharmacoepidemiological registry studies. Personal integrity and the EEC legislation]A Wessling, U Bergman
WHO Regional Publications. European Series|January 1, 1993
The quantification of drug risks in practiceD Lee, U Bergman
BMJ (Clinical Research Ed.)|October 17, 1998
Use of calcium channel blockers and risk of suicide. Independent studies are needed before causality is establishedU Bergman, G Isacsson
Acta Medica Scandinavica. Supplementum|January 1, 1984
Measurement of drug utilization in Sweden: methodological and clinical implicationsU Bergman, F Sjöqvist
Lakartidningen|June 17, 1992
[Severe adverse effect of the anti-allergy drug loratadine--warning against prolonged use of non-prescription drugs]K Nyman, U Bergman
Lancet (London, England)|August 7, 1993
Benzodiazepine use in SwedenU Bergman, M Myrhed
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
Lakartidningen|April 10, 1996
[Lists presented by eight drug committees compared. The number of preparations varies. Similar views on the most expensive drugs]U Bergman, M Myrhed
Lancet (London, England)|October 12, 1996
Risks with citalopram in perspectiveG Isacsson, U Bergman
NIDA Research Monograph|January 1, 1989
Current approaches to measurement of drug use and abuse in SwedenU Bergman, D Lee
Lakartidningen|July 27, 1994
[Uppsala at the bottom, Kopparberg at the top of the glaucoma list. Big differences in drug utilization]B Calissendorff, U Bergman
Lakartidningen|August 24, 1994
[Pharmacoepidemiological registry studies. Personal integrity and the EEC legislation]A Wessling, U Bergman
WHO Regional Publications. European Series|January 1, 1993
The quantification of drug risks in practiceD Lee, U Bergman
BMJ (Clinical Research Ed.)|October 17, 1998
Use of calcium channel blockers and risk of suicide. Independent studies are needed before causality is establishedU Bergman, G Isacsson
Acta Medica Scandinavica. Supplementum|January 1, 1984
Measurement of drug utilization in Sweden: methodological and clinical implicationsU Bergman, F Sjöqvist
Lakartidningen|June 17, 1992
[Severe adverse effect of the anti-allergy drug loratadine--warning against prolonged use of non-prescription drugs]K Nyman, U Bergman
Lancet (London, England)|August 7, 1993
Benzodiazepine use in SwedenU Bergman, M Myrhed
Pageof 12